Zachary Verne joins Ethics Talk to discuss his article, coauthored with Dr Jeffrey Zabinski: “How Should We Expand Access to Psychedelics While Maintaining an Environment of Peace and Safety?”

The Indian Health Service has been a leader in implementing telehealth programs and technologies that increase access to and efficiencies in care, particularly in the fields of mental health and ophthalmology.

Researchers and clinicians face ethical and policy-based challenges in disclosing, preventing and treating psychosis. Which diagnostic labels should be considered to motivate more effective public and professional dialogue about psychosis risk?

Although the stigma of the psychosis risk label can cause harm, the label can also confer benefit and provides an explanatory framework for symptoms.

Even if a placebo is safe, it should not be employed as a way of mollifying patients or glossing over underlying causes of illness.

The medicalization of addiction has greatly improved identification, early intervention, and referral to appropriate treatment.

This article examines widespread adoption of ketamine as a proxy for psychedelics.

An aging prison population means more people who are incarcerated will experience dementia and related symptoms.